Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease

被引:47
|
作者
Kim, SH
Cairns, N
Fountoulakisc, M
Lubec, G
机构
[1] Univ Vienna, Dept Pediat, A-1090 Vienna, Austria
[2] Kings Coll London, Inst Psychiat, Brain Bank, London WC2R 2LS, England
[3] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
基金
英国医学研究理事会;
关键词
histamine-releasing factor; histaminergic deficits; Down syndrome; Alzheimer's disease; neurodegenerative/dementing disorders;
D O I
10.1016/S0304-3940(01)01545-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Histamine-releasing factor (HRF) stimulates secretion of histamine that is widely distributed in brain and released as neurotransmitter. Several studies suggested that histaminergic deficits could contribute to the cognitive decline in Alzheimer's disease (AD). Based upon deranged histamine metabolism in brain of patients with AD and Down Syndrome (DS), we aimed to study HRF in brain of AD and DS. We used two-dimensional gel electrophoresis, matrix-assisted laser desorption ionization mass spectroscopy and specific software to quantify HRF. HRF was significantly reduced in temporal cortex, thalamus and caudate nucleus of DS and in temporal cortex of AD as compared to controls. This is the first report to show decreased HRF brain levels in DS and AD suggesting the explanation for the decreased cognitive function in neurodegenerative/dementing disorders. (C) 2001 Elsevier Science Ireland Ltd. Ail rights reserved.
引用
收藏
页码:41 / 44
页数:4
相关论文
共 50 条
  • [1] Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down Syndrome and Alzheimer's disease
    Greber, S
    Lubec, G
    Cairns, N
    Fountoulakis, M
    ELECTROPHORESIS, 1999, 20 (4-5) : 928 - 934
  • [2] Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome
    Shim, KS
    Lubec, G
    NEUROSCIENCE LETTERS, 2002, 324 (03) : 209 - 212
  • [3] Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease
    Cheon, MS
    Fountoulakis, M
    Cairns, NJ
    Dierssen, M
    Herkner, K
    Lubec, G
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2001, (61): : 281 - 288
  • [4] Human brain nucleoside diphosphate kinase-A is decreased in Alzheimer's disease and Down syndrome
    Kim, SH
    Lubec, G
    Fountoulakis, M
    Hoffmann-La Roche, F
    Cairns, NJ
    Bank, B
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S180 - S181
  • [5] Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome
    Kim, SH
    Fountoulakis, M
    Cairns, NJ
    Lubec, G
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (04) : 970 - 975
  • [6] HISTAMINE-RELEASING FACTOR(S) IN SERA OF UREMIC PRURITUS PATIENTS IN A POSSIBLE MECHANISM OF UVB THERAPY
    IMAZU, LE
    TACHIBANA, T
    DANNO, K
    TANAKA, M
    IMAMURA, S
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1993, 285 (07) : 423 - 427
  • [7] Heat-shock protein 70 levels in brain of patients with Down Syndrome and Alzheimer's disease
    Yoo, BC
    Seidl, R
    Cairns, N
    Lubec, G
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (57): : 315 - 322
  • [8] Human brain nascent polypeptide-associated complex α subunit is decreased in patients with Alzheimer's disease and Down syndrome
    Kim, SH
    Shim, KS
    Lubec, G
    JOURNAL OF INVESTIGATIVE MEDICINE, 2002, 50 (04) : 293 - 301
  • [9] Cytoskeleton derangement in brain of patients with Down Syndrome, Alzheimer's disease and Pick's disease
    Pollak, D
    Cairns, N
    Lubec, G
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2003, (67): : 149 - 158
  • [10] Human brain cytosolic histamine-N-methyltransferase is decreased in Down syndrome and increased in Pick's disease
    Kim, SH
    Krapfenbauer, K
    Cheon, MS
    Fountoulakis, M
    Cairns, NJ
    Lubec, G
    NEUROSCIENCE LETTERS, 2002, 321 (03) : 169 - 172